Drug shortage
Morphine Sulfate Injection · Piramal Critical Care Inc.
FDA drug shortage · Current · updated Apr 15, 2025
Key facts
| Generic name | Morphine Sulfate Injection |
|---|---|
| Proprietary name | Mitigo (Morphine Sulfate Injection, Usp) |
| Company | Piramal Critical Care Inc. |
| Presentation | Mitigo (Morphine Sulfate Injection, USP), Injection, 500 mg/20 mL (NDC 66794-162-02) |
| Dosage form | Injection |
| Strength | 500 mg/20 mL |
| Status | Current |
| Reason for shortage | Demand increase for the drug |
| Therapeutic category | Analgesia/Addiction |
| Package NDCs | 66794-162-02 |
| First posted | Oct 31, 2017 |
| Last updated | Apr 15, 2025 |
At a glance
- 1–9 Package NDCs affected
- 10–99 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: